UPDATE : Monday, February 17, 2020
Patients may file class-action lawsuit against Kolon for mislabeling Invossa by Jeong Sae-im 2019-04-10 14:41
Hanmi, Enzychem challenge Amgen in neutropenia treatment by Jeong Sae-im 2019-04-09 12:15
Dong-A ST’s investigational drug posts positive study results by Jeong Sae-im 2019-04-08 16:00
Kolon’s foreign partners await cell analysis results by Jeong Sae-im 2019-04-08 14:28
Kolon Life Science criticized for poor quality control on Invossa by Jeong Sae-im 2019-04-05 12:27
‘Invossa, first treatment to have used cancerous cell lines’ by Jeong Sae-im 2019-04-04 15:24
[Special] MSD Korea makes wrong excuse on external monitoring by Jeong Sae-im 2019-04-03 16:59
‘Paternity testing’ would have prevented Invossa debacle by Jeong Sae-im 2019-04-02 15:27
[Special] MSD Korea asks monitoring agents to record talks ‘discreetly’ by Jeong Sae-im 2019-04-02 14:45
[Special] Why doctors got upset with MSD Korea’s monitoring program by Jeong Sae-im 2019-04-01 14:22
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe by Jeong Sae-im 2019-03-27 16:16
‘Remimazolam has fewer side effects than propofol’ by Jeong Sae-im 2019-03-27 15:05
Huons Medicare wins CE certification for medical disinfectant by Jeong Sae-im 2019-03-27 13:55
‘MSD Korea excessively monitors workers, collects client info without consent’ by Jeong Sae-im 2019-03-22 13:49
Health minister asks AI-backed drug-developing support center to go bolder by Jeong Sae-im 2019-03-21 14:44
Il-yang, Hanmi achieve robust sales growth in China by Jeong Sae-im 2019-03-19 11:21
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’ by Jeong Sae-im 2019-03-18 15:03
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case by Jeong Sae-im 2019-03-15 11:41
Loss-making Medipost seeks to avoid administrative issue designation by Jeong Sae-im 2019-03-14 14:33
Drugmakers to name new CEOs, enhance ownership by Jeong Sae-im 2019-03-12 16:17
Back to Top